Back
Swedbank AB Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
64
SWDBY
Swedbank AB
Last Price:
$26.86
Seasonality Move:
5.29%
Buy
59
RYTM
Rhythm Pharmaceuticals
Last Price:
$62.59
Seasonality Move:
94.21%
Buy
64
Swedbank AB (SWDBY)
is a Buy
Is Swedbank AB a Buy, Sell or Hold?
-
The current Swedbank AB [SWDBY] share price is $26.86. The Score for SWDBY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
SWDBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $62.41. The Score for RYTM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SWDBY Stock Price Chart
What is Swedbank AB's stock price today?
-
The Swedbank AB share price today is $26.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWDBY is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $62.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
SWDBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.84 | Buy |
| Relative Strength Index (14 RSI): | 72.94 | Buy |
| Chaikin Money Flow: | -13841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.48 - 26.12) | Buy |
| Bollinger Bands (100): | (21.14 - 25.42) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 54.66 | Buy |
| Chaikin Money Flow: | -241047 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.19 - 64.21) | Buy |
| Bollinger Bands (100): | (53.12 - 61.2) | Buy |
SWDBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.18 | Buy |
| 20-day SMA: | 25.29 | Buy |
| 50-day SMA: | 24.27 | Buy |
| 200-day SMA: | 21.83 | Buy |
| 8-day EMA: | 26.27 | Buy |
| 20-day EMA: | 25.38 | Buy |
| 50-day EMA: | 24.39 | Buy |
| 200-day EMA: | 22.36 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.08 | Buy |
| 20-day SMA: | 61.99 | Buy |
| 50-day SMA: | 57.89 | Buy |
| 200-day SMA: | 54.66 | Buy |
| 8-day EMA: | 61.25 | Buy |
| 20-day EMA: | 60.84 | Buy |
| 50-day EMA: | 59.16 | Buy |
| 200-day EMA: | 54.12 | Buy |
Swedbank AB Earnings Growth & SWDBY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $0.08 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Swedbank AB Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||